ScreenerHero
VIROViroGates A/S
CPH · DK · Healthcare · Medical Devices · virogates.com
11.60DKK+6.42%Mkt Cap: 15.68M $P/E: —

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidime…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$198.81BUSDP/E 36.9
SYK
STRYKER CORP. R
$120.66BUSDP/E 34.7
SYK
Stryker Corporation
$125.70BUSDP/E 33.9
2M6
Medtronic plc
$111.66BUSDP/E 24.9
BSX
Boston Scientific Corporation
$75.37BUSDP/E 21.1
EW
Edwards Lifesciences Corporation
$53.13BUSDP/E 54.9
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
GEHC
GE HealthCare Technologies Inc. Common Stock
$33.94BUSDP/E 17.2
DXCM
DexCom, Inc.
$33.92BUSDP/E 35.5
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
ZBH
Zimmer Biomet Holdings, Inc.
$19.21BUSDP/E 24.5
SOON
Sonova Holding AG
$16.48BUSDP/E 26.9
PEN
Penumbra, Inc.
$12.87BUSDP/E 80.5
GMED
Globus Medical, Inc.
$11.86BUSDP/E 22.6
GKOS
Glaukos Corp
$11.18BUSD
EUZ
Eckert & Ziegler SE
$10.01BUSDP/E 17.1
PODD
Insulet Corporation
$10.51BUSDP/E 28.4
SN
Smith & Nephew plc
$9.73BUSDP/E 19.8
BIO
Bio-Rad Laboratories, Inc. Class A
$9.75BUSDP/E 44.3
DEMANT
Demant A/S
$8.82BUSDP/E 25.0

Key Statistics

Company
Market Cap15.68M $
Enterprise Value12.11M $
Revenue (TTM)1.31M $
Gross Profit964.36K $
Net Income (TTM)-1.51M $
Revenue/Share0.1413 USD
Last Price11.60 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountryDK
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue9.23
P/S11.24
P/B6.03
EPS (TTM)-1.24
EPS (Forward)—
52W Range
9.05031% of range17.40
52W High17.40 DKK
52W Low9.050 DKK
Profitability
Gross Margin74.36%
Oper. Margin-220.26%
EBITDA Margin0.00%
Profit Margin-116.77%
ROE-53.58%
ROA-33.99%
Growth
Revenue Growth8.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-600.82K $
CapEx (TTM)—
FCF Margin-40.77%
FCF Yield-3.41%
Net Debt-2.63M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.24
Current Ratio3.82
Quick Ratio3.50
Book Value/Sh1.809 DKK
Cash/Share2.400 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.28M
Float2.37M
Insiders74.50%
Institutions0.00%
Technical
SMA 5010.20 (+13.7%)
SMA 20011.65 (-0.4%)
Beta0.59
S&P 52W Chg18.16%
Avg Vol (30d)382
Avg Vol (10d)191
Technical Indicators
RSI (14)54.5
MACD0.1452
MACD Signal0.0459
MACD Hist.+0.0993
BB Upper11.88 DKK
BB Middle10.15 DKK
BB Lower8.421 DKK
BB Width34.06%
ATR (14)0.6599 DKK
Vol Ratio (20d)0.00x